Vivo Bio Tech Ltd shareholders have approved the re-appointment of Mr. Kalyan Ram Mangipudi as Whole-time Director and sanctioned related party transactions involving a promoter appointment and dealings with M/s. Virinchi Limited. The resolutions were passed via a postal ballot process that concluded on July 14, 2026, with the requisite majority as per the scrutinizer's report.

The postal ballot sought shareholder approval for three key resolutions. The first concerned the re-appointment of Mr. Kalyan Ram Mangipudi (DIN: 02012580) as the Whole-time Director of the Company. The second resolution involved a related party transaction to appoint Mrs. Madhavi Latha Kompella, a Promoter, as an Advisor for Strategy & Business Development for a term of five years from October 01, 2026, to September 30, 2031. The third resolution sought approval for material related party transactions with M/s. Virinchi Limited.

Voting Results

The remote e-voting facility was open from June 15, 2026, to July 14, 2026. The scrutinizer, CS Vinay Babu Gade, confirmed that the votes were unblocked on July 14, 2026, in the presence of witnesses. A total of 21,589 shareholders were on the record date of June 05, 2026. The voting results indicated strong support from the public non-institutional shareholders, while promoter votes were not cast.

Scrutinizer's Findings

The scrutinizer's report confirmed that all three resolutions were passed with the required majority. The report noted that there were no invalid votes recorded for any of the resolutions. The voting was conducted entirely through remote e-voting, with no physical polling or postal ballot forms utilized. The results were declared based on the collation of votes provided by the service provider, Central Depository Services (India) Limited (CDSL).

The disclosures were made in compliance with Regulation 30 and 44(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The detailed voting results and the scrutinizer's report have been made available on the company's website.

Vivo Bio Tech Ltd appointed Bhavish Vijayvargiya as Company Secretary and Compliance Officer effective June 24, 2026, following the resignation of Mr. A V Kiran. The Board of Directors approved the appointment during a meeting held on June 24, 2026, which commenced at 4:00 P.M. and concluded at 4:20 P.M. Mr. A V Kiran resigned to pursue alternate career opportunities outside the organization and was relieved from his responsibilities with effect from June 24, 2026.

Mr. Bhavish Vijayvargiya has been designated as a Whole-Time Key Managerial Personnel (KMP) of the company. He is an Associate Member of the Institute of Company Secretaries of India, holding Membership No. A77631. His experience includes core areas of Corporate Secretarial functions and Compliance management.

The appointment was made pursuant to Section 203 of the Companies Act 2013 and Regulation 6(1) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The disclosures were made in compliance with Regulation 30 read with Part A, Para A of Schedule III of the SEBI Regulations, 2015 and SEBI Circular No SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024. The company subsequently submitted a clarification to BSE Limited on June 29, 2026, regarding the inadvertent omission of the Board meeting commencement and conclusion times in the initial announcement.

Details of Appointment and Resignation

The following table outlines the key details regarding the change in the Company Secretary and Compliance Officer position:

The Board has authorised Mr. Bhavish Vijayvargiya to determine the materiality of an event or information and for advising on disclosures to the stock exchanges. The contact details for the authorized person are provided below:

Name: Bhavish Vijayvargiya Designation: Company Secretary & Compliance Officer Address: 3rd Floor, Ilyas Mohammed Khan Estate#8-2-672/5 & 6, Road No. 1, Banjara Hills, Hyderabad, Telangana – 500034. Email: investor@vivobio.com Phone: 040-23313288